Condition: Appendix Cancer · Appendiceal Cancer · Appendiceal Neoplasms · Sponsor: Andreana Holowatyj, PhD, MSCI
The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.
This description comes directly from the study's public registry record.
GAP Study Coordinator (Rebecca B.) · 615-936-8544 · gapcancerstudy@vumc.org
Always discuss trial participation with your own doctor first.
| Vanderbilt-Ingram Cancer Center | Nashville, Tennessee, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05734430